Determination of platinum and palladium in strongly acid solution by means of flow injection analysis

Microamounts of Pt(II/IV) (0.25–800 μg/ml) and Pd(II) (5–600 μg/ml) in> 0.5 M hydrochloric acid can readily be determined by means of a simple FIA method based on the selective reaction of tin(II)chloride with these metals. The FIA method has a high linear dynamic range, and is relatively free from interferences of many transition metals, with the exception of Au and Rh; small amounts of other PGMs can be tolerated. Determination of Pt on a hydrogenation catalyst by this method compares well with that found by flame atomic absorption spectroscopy. By monitoring at two or more wavelengths, Pt and Pd can be determined in mixtures by this means, to yield a simple, cost-effective FIA method for possible on-line determinations and quality control of, in particular, Pt containing acidic refinery and other process streams.     

Determination of orotic acid in urine by capillary zone electrophoresis in tandem-coupled columns with diode array detection

Analytical potentialities of capillary zone electrophoresis in the separation system with tandem-coupled columns to the spectral identification and determination of orotic acid (OA) in urine by diode array detection (DAD), coupled to the separation system via optical fibers, were investigated. A very significant “in-column” clean-up of OA from urine matrix was reached in the separation stage of the tandem by combining a low pH (2.8) with complexing effects of electroneutral agents [- and β-cyclodextrins, poly(vinylpyrrolidone) and 3-(N,N-dimethyldodecylammonio)propanesulfonate]. Due to this, its DAD spectral data could be acquired in the detection stage of the tandem with almost no disturbances by matrix co-migrants. The concentration limits of detection obtained under such working conditions for a 200-nl sample load of OA and 320 μm I.D. capillary tubes were 3.5 μmol/l (218 nm) and 0.4 μmol/l (280 nm). Using chemometry procedures (target transformation factor analysis, fixed size moving window-evolving factor analysis, orthogonal projection approach and fixed size moving window–target transformation factor analysis) in processing of the acquired spectral data, the presence of OA in the loaded urine matrix could be confirmed with confidence when its concentration was 10 μmol/l or slightly less.     

Micro flow injection analysis combined with a separation technique for the urinary glucose assay.

A urinary glucose assay has been investigated, employing a micro flow injection analysis (microFIA) combined with a separation technique of glucose from the analyte. The adsorption part using activated alumina for the glucose in the analyte can be successively integrated onto a microFI chip. The selective adsorption-desorption of glucose in the artificial urine can progress on the adsorption part. Along with this selective preconcentration of glucose, the typical FI peak of glucose can be obtained just by feeding the sample and deionized water as an elutant sandwiched with the reagent on the carrier stream. The glucose concentration in artificial urine can be quantitatively determined with the present microFIA system, while the interference of other components coexisting in urine occurs in the case of the conventional FIA system without any separation part. The described method serves as a template for improving the selectivity for the analyte in the multi-component system.     

Flow injection analysis of zinc pyrithione in hair care products on a cobalt phthalocyanine modified screen-printed carbon electrode

Zinc pyrithione (ZPT) is an antibacterial and antifungal reagent that is often utilized for the antidandruff activity in hair-care shampoos with a composition level up to 1% in the formulation. It has some adverse effects to human and animal if consumed orally. A disposable type of cobalt phthalocyanide modified screen-printed carbon electrode (CoPc/SPE) in couple with flow injection analysis (FIA) was developed for easy and selective analysis of ZPT in commercial hair-care products. Under the optimized FIA conditions, the CoPc/SPE yielded a linear calibration plot in the window of 6–576 μM with sensitivity and detection limit of 1.65 nA μM⁻¹ and 0.9 μM (i.e. 1.42 pg in 5 μl sample loop), respectively, in 0.1 M KOH solution at an applied potential of 0.3 V versus Ag/AgCl. Since the approach is simple, easy, selective, and inexpensive, it offers a potential application of daily ZPT analysis in hair-care products.     

Spectrophotometric determination of total phenolics by solvent extraction and sorbent extraction optosensing using flow injection methodology

Flow injection analysis (FIA) procedures for the Spectrophotometric determination of phenol involving in-line concentration by solvent and sorbent extraction have been developed. The imine product formed in the reaction between phenol and 4-aminoantipyrine (4-AAP) is either extracted into chloroform (solvent extraction) or is temporarily retained on C₁₈-modified silica material contained in a microcolumn (sorbent extraction). In the latter case two variants of detection have been used namely the Spectrophotometric measurement of the methanolic eluent containing the concentrated dye and at-column optosensing of the retained reaction product followed by methanol elution to maintain reversibility of the process. In the solvent extraction procedure a 10-fold increase of sensitivity compared to the common FIA method without extraction is achieved but no corresponding improvement in detectability is observed. Under optimized conditions the detection limit amounts to 8 μg l⁻¹. Using sorbent extraction methodology, high concentration factors can be obtained when large sample volumes are used. The only limitation in getting correspondingly lower detection limits are an increasingly high and variable blank value with sampling volume. The detection limits obtained for measurement of the absorbance in the eluent and on-column optosensing are 11 μg l⁻¹ and 0.4 μg l⁻¹, respectively. A study of the extractability of various phenol derivates using both solvent and sorbent extraction revealed lower relative response rates compared to the FIA method without extraction. Phenolics that possess an additional acidic group are present in ionized form at the high pH of the assay and are not extractable at all.     

Dosage du baryum dans l''eau et les liquides biologiques par spectrometrie d''emission avec source plasma haute frequence

Determination of barium in water and biological fluids by emission spectrometry with an inductively-coupled plasma

An emission spectrometric method is described for the determination of barium in water urine and blood with an inductively-coupled plasma. The method is highly selective, reproducible, and sensitive. The limits of detection are 0.06 μg l^-1 in water, 0.25 μg l^-1 in urine, 0.6 μg l^-1 in blood. For thirteen healthy subjects, the barium content was 4.3 μg l^-1 (s = 1.4) in urine and less than 1 μg l^-1 in blood. For a case of accidental poisoning, the content was 260 μg Ba l^-1 in blood and 280 μg Ba l^-1 in urine.     

Determination of gamma-hydroxybutyric acid in human urine by capillary electrophoresis with indirect UV detection and confirmation with electrospray ionization ion-trap mass spectrometry

γ-Hydroxybutyric acid (GHB), a minor metabolite or precursor of γ-aminobutyric acid (GABA), acts as a neurotransmitter/neuromodulator via binding to GABA receptors and to specific presynaptic GHB receptors. Based upon the stimulatory effects, GHB is widely abused. Thus, there is great interest in monitoring GHB in body fluids and tissues. We have developed an assay for urinary GHB that is based upon liquid–liquid extraction and capillary zone electrophoresis (CZE) with indirect UV absorption detection. The background electrolyte is composed of 4 mM nicotinic acid (compound for indirect detection), 3 mM spermine (reversal of electroosmosis) and histidine (added to reach a pH of 6.2). Having a 50 μm I.D. capillary of 40 cm effective length, 1-octanesulfonic acid as internal standard, solute detection at 214 nm and a diluted urine with a conductivity of 2.4 mS/cm, GHB concentrations ≥2 μg/ml can be detected. Limit of detection (LOD) and limit of quantitation (LOQ) were determined to be dependent on urine concentration and varied between 2–24 and 5–60 μg/ml, respectively. Data obtained suggest that LOD and LOQ (both in μg/ml) can be estimated with the relationships 0.83 κ and 2.1 κ, respectively, where κ is the conductivity of the urine in mS/cm. The assay was successfully applied to urines collected after administration of 25 mg sodium GHB/kg body mass. Negative electrospray ionization ion-trap tandem mass spectrometry was used to confirm the presence of GHB in the urinary extract via selected reaction monitoring of the m/z 103.1→m/z 85.1 precursor–product ion transition. Independent of urine concentration, this approach meets the urinary cut-off level of 10 μg/ml that is required for recognition of the presence of exogenous GHB. Furthermore, data obtained with injection of plain or diluted urine indicate that CZE could be used to rapidly recognize GHB amounts (in μg/ml) that are ≥ 4 κ.     

Determination of tannic acid by direct chemiluminescence in a FIA assembly

The determination of tannic acid is performed in a FIA assembly on the basis of the analytical output obtained by oxidation of the acid. The analyte solution was daily prepared in a mixture of quinine as sensitiser and perchloric acid and it was injected into a pure water stream acting as a carrier. This solution merges with the mixture potassium permanganate in perchloric medium and the resulting chemiluminescence is monitored. The method was applied over the range 0.5–20 mg l⁻¹ of tannic acid with a LOD 100 μg l⁻¹. The reproducibility was 2.1% and the sample throughput 54 h⁻¹. The influence of foreign substances was studied and the new method is applied to the determination of tannic acid in pharmaceutical and galenic formulations in human urine and surface waters.     

A hybrid FIA/HPLC system incorporating monolithic column chromatography

We have combined the generation of solvent gradients using milliGAT pumps, chromatographic separations with monolithic columns and chemiluminescence detection in an instrument manifold that approaches the automation and separation efficiency of HPLC, whilst maintaining the positive attributes of flow injection analysis (FIA), such as manifold versatility, speed of analysis and portability. As preliminary demonstrations of this hybrid FIA/HPLC system, we have determined six opiate alkaloids (morphine, pseudomorphine, codeine, oripavine, ethylmorphine and thebaine) and four biogenic amines (vanilmandelic acid, serotonin, 5-hydroxyindole-3-acetic acid and homovanillic acid) in human urine, using tris(2,2′-bipyridyl)ruthenium(III) and acidic potassium permanganate chemiluminescence detection.     

Critical study of fluorimetric determination of selenium in urine

Different steps for the fluorimetric determination of Se in urine have been investigated. A HNO₃---HClO₄ (4:1) mixture is useful for urine digestion, and reduction of Se(VI) to Se(IV) is effectively carried out with HCl (6M). Selenium(VI) present after the digestion process constitutes 14.5–36.6% of total Se. An optimum pH of 1.80±0.05 and the addition of 1 ml of 2,3-diaminonaphthalene (DAN) (0.1%, w/v) are established in the formation of Se—DAN complex. Heating to 60°C, a time of incubation of 15 min is recommended to assure the complete formation of Se—DAN complex. A volume of 5 ml of cyclohexane and vigorous shaking for 45 sec is necessary for the extraction process. With this optimized method, the detection limit of selenium was 0.82 μg/l., within-day precision for a 50.0 μg/l. standard solution and urine (27.3 μg/l.) were 2.4 and 2.7% and between-day for the urine was 3.9% (33.9 μg/l.). Analytical recovery of 0.5 ml of Se standard (250 μg/l.) added to 1 ml of urine was 99.9±2.9% (95.8–104.4, n = 12). Normal levels of selenium excretion in urine obtained from healthy people were 27.9±8.7 μg/day (13.2–44.1), not observing significant differences (P < 0.05) between sexes.     

Flow injection hydride generation electrothermal atomic absorption spectrometric determination of toxicologically relevant arsenic in urine

Analytical procedure for the determination of toxicologically relevant arsenic (the sum of arsenite, arsenate, monomethylarsonate and dimethylarsinate) in urine by flow injection hydride generation and collection of generated inorganic and methylated hydrides on an integrated platform of a transverse-heated graphite atomizer for electrothermal atomic absorption spectrometric determination (ETAAS) is elaborated. Platforms are pre-treated with 2.7 μmol of zirconium and then with 0.10 μmol of iridium which serve both as an efficient hydride sequestration medium and permanent chemical modifier. Arsine, monomethylarsine and dimethylarsine are generated from diluted urine samples (10–25-fold) in the presence of 50 mmol L⁻¹ hydrochloric acid and 70 mmol L⁻¹ l-cysteine. Collection, pyrolysis and atomization temperatures are 450, 500, 2100 and 2150 °C, respectively. The characteristic mass, characteristic concentration and limit of detection (3σ) are 39 pg, 0.078 μg L⁻¹ and 0.038 μg L⁻¹ As, respectively. The limits of detection in urine are ca. 0.4 and 1 μg L⁻¹ with 10- and 25-fold dilutions. The sample throughput rate is 25 h⁻¹. Applications to several urine CRMs are given.     

A selective voltammetric method for uric acid detection at Nafion(R)-coated carbon paste electrodes

A square-wave voltammetric method together with Nafion®-coated carbon paste electrodes were used for the selective determination of uric acid in the presence of a high concentration of ascorbic acid. Since the oxidation potential of uric acid is about 200 mV more positive than that of ascorbic acid at the Nafion®-coated carbon paste electrode, the selectivity can be greatly improved simply by applying an electrolysis potential of +0.4 V vs. Ag/AgCl where only ascorbic acid is oxidised. The acceptable tolerance of ascorbic acid concentration for the determination of uric acid is as high as 1.5 mM. With 30 s of electrolysis time, a linear calibration curve is obtained over the 0–50 μM range in 0.05 M citrate buffer solution, pH 4.0, with slope (μA/μM) and correlation coefficient of 0.34 and 0.9984, respectively. The detection limit (3σ) is 0.25 μM. The practical analytical utility is illustrated by selective measurements of uric acid in human urine without any preliminary treatment.     

Direct analysis of reference biofluids by coupled in situ electrodeposition-electrothermal atomic absorption spectrometry

The application of coupled in situ electrodeposition-electrothermal atomic absorption spectrometry (ED-ETAAS) to the determination of Pb in biological standard reference materials is described. In situ electrodeposition at a cell voltage of 3.0 V from 25-μl samples onto electrodeposited Pd is used to quantitatively separate the analyte from blood and urine matrices. With subsequent withdrawal of spent electrolyte, this overcomes the atomisation problems inherent with high salt and organic contents. ED-ETAAS is applied with minimal sample pre-treatment (acidification). The electrolysis process aids decomposition of the organic matrix, and the release of trace elements. Evolution of H₂ at the cathode counters fouling of the Pd modifier surface. The palladium deposit is renewed in situ for each determination. For AMI certified lyophilised blood, diluted 1+3 with 0.1 M HCl (18.1 μg/l Pb), the R.S.D. was 3.0% (peak height; n=5) and the detection limit (3 σ_blank; n=5) was 1.5 μg/l. Results for certified blood samples were AMI 72.3±4.3 μg/l (certified 76.2±7.6 μg/l) and Seronorm 34.2±2.0 μg/l (36±4 μg/l). The result for NIST SRM 2670 normal urine acidified to 1% HNO₃ was 8.1±0.6 μg/l (recommended value 10 μg/l).     

On-line focused microwave digestion-hydride generation of inorganic and organic selenium: Total determination and inorganic selenium speciation by atomic absorption spectrometry

An on-line FIA pretreatment with HBr/KBrO₃, assisted by on-line focused microwave-induced digestion, has been coupled with hydride generation-atomic absorption spectrometry (HG-AAS) for final detection for total selenium determination. This total selenium determination is virtually independent of the different Se species investigated (selenite, selenate, selenomethionine, selenoethionine and selenocystine). Detection limits of 0.8 μg l⁻¹ of Se can be achieved by AAS with precisions better than 5%. This continuous flow system for selenium determination allows a high sample throughput (about 30 samples h⁻¹ can be analyzed) in which high automation can be achieved and constitutes a convenient real-time continuous detector for the different selenocompounds tested. Direct non-chromatographic speciation of inorganic selenium (selenite and selenate in their mixtures) is demonstrated by simple on-off operation of the focused microwaves connected in the flow system.

Validation of this simple on-line FIA system has been carried out by analyzing total Se recovered from spiked tap waters and by speciating mixtures of Se(IV) and Se(VI) spiked to the same samples. The fast conversion of Se compounds into volatile selenium could be considered as a sort of specific “general” detector for Se compounds which can be extremely useful for Se speciation by hybrid chromatographic techniques.     

An optimization procedure for determination of indomethacin and acemethacin by differential pulse adsorptive stripping voltammetry. Application on urine samples

Procedures for the determination of indomethacin and acemethacin by differential pulse adsorptive stripping voltammetry with a mercury electrode have been described and optimised. The selection and optimization of the experimental parameters was done using factorial and central composite designs. Indomethacin and acemethacin in urine were determined by this method with good results and without the need for tedious prior separation. For routine calibration and calculation of the ‘capacity to detect’, the robust regression method least median squares (LMS) has been proposed.     

Determination of dioxopromethazine hydrochloride by capillary electrophoresis with electrochemiluminescence detection

The paper presents a rapid method for the determination of dioxopromethazine hydrochloride (DPZ), an antihistamine drug, by the capillary electrophoresis with electrochemiluminescene detection (CE–ECL) using tris(2,2′-bipyridyl)ruthenium(II) (Ru(bpy)₃²⁺) reagent. This CE–ECL detection method has high sensitivity, good selectivity and reproducibility for DPZ analysis. Under the optimized conditions: separation capillary, 38 cm length (25 μm i.d.); sample injection, 10 s at 8 kV; separation voltage, 12.5 kV; running buffer, 20 mmol L⁻¹ sodium phosphate of pH 6.0; detection potential, 1.15 V; 50 mmol L⁻¹ of phosphate buffer (pH 7.14) containing 5 mmol L⁻¹ of Ru(bpy)₃²⁺ in ECL detection cell, the detection limit of DPZ was 0.05 μmol L⁻¹ (S/N = 3). The linear range extended from 5 to 100 μmol L⁻¹. The linear curve obtained was Y = 181.62 + 9.28X with a correlation coefficient of 0.9970. The relative standard deviations of the ECL intensity and the migration time for six continuous injections of 5 μmol L⁻¹ DPZ were 3.7% and 0.92%, respectively. The CE–ECL method was applied to analyze DPZ in real samples including tablets, rat serum and human urine, and satisfactory results were obtained without interference from samples matrix. The CE–ECL technique was proved to be a potential method for the detection of DPZ in clinic analysis.     

A new immune resonance scattering spectral assay for trace fibrinogen with gold nanoparticle label

An on-line stacking method based on moving reaction boundary (MRB) was developed for the sensitive determination of barbital and phenobarbital in human urine via capillary electrophoresis (CE). The optimized conditions for the method are: 60 mmol L⁻¹ pH 11.0 Gly–NaOH as the background electrolyte, 10 mmol L⁻¹ pH 5.5 Gly–HCl as sample buffer, secobarbital as the internal standard (IS), 12.5 kV, 1.4 psi 10 s sample injection, 75 μm ID 60.2 cm total length (50 cm effective length) capillary and 214 nm detect wavelength. Under the optimized conditions, the method can well stack and separate barbital and phenobarbital in urine samples and result in 20.5-fold and 22.6-fold improvement in concentration sensitivity for barbital and phenobarbital, respectively. Furthermore, the method holds: (1) good linear calibration functions for the two target compounds (correlation coefficients r > 0.999), (2) low limits of detection (0.27 μg mL⁻¹ for barbital and 0.26 μg mL⁻¹ for phenobarbital), (3) low limits of quantification (0.92 μg mL⁻¹ for barbital and 0.87 μg mL⁻¹ for phenobarbital), (4) good precision (R.S.D. of intra-day and inter-day less than 5.38% for barbital and 1.67% for phenobarbital, respectively) and (5) high recoveries at three concentration levels (90.27–106.36% for barbital and 93.05–113.60% for phenobarbital in urine). The method is simple, sensitive and efficient, and can fit to the need of clinical and forensic toxicology.     

Fe analysis by the ferrozine method: Adaptation to FIA towards in situ analysis in hydrothermal environment

The target of this study is the adaptation of the ferrozine method to flow injection analysis (FIA) to perform iron analysis in situ using an in situ chemical analyser in hydrothermal environments. The adaptation of the method to FIA was followed by its optimisation using an experimental design screening method. The goals of the optimisation steps were to decrease the detection limit and to increase the measuring range to cope with the constraints of in situ analysis. The method allows the determination of iron in the mixing zone of hydrothermal fluid, enriched in iron, and seawater. A single manifold gives the possibility to analyse either Fe(II) or ΣFe [Fe(II) + Fe(III)] in situ, or ΣFe in the lab on hydrothermal seawater samples. The measuring range of the method was increased to up to 2000 μM, which is coherent with the study of the chemical environment of communities associated with deep-sea hydrothermal activity. Finally, the method was applied in situ using the chemical analyser Alchimist during the ATOS cruise on hydrothermal vent fields on the Mid Atlantic Ridge.     

Elimination profiles of flurbiprofen and its metabolites in equine urine for doping analysis

Flurbiprofen and its main acidic metabolites were detected in equine urine after a single-dose administration of 500 mg flurbiprofen to two 2.5–3.5-years-old mares, in order to be used in equine doping control routine analysis. The urine levels of the parent drug were determined using GC/MS. Five acidic metabolites were found in the urine. The structure of the proposed metabolites was confirmed by HRMS accurate mass measurements. The highest flurbiprofen concentration was 204 μg ml⁻¹ at 1–3 h post administration. Flurbiprofen could be detected for 24–37 h in urine using the standard screening procedure. All metabolites were present 25 h post administration, while 4′-hydroxyflurbiprofen could be traced for more than 48 h and it is regarded as the long-term metabolite of flurbiprofen in horse.     

Solubilisation and binding characteristics of a recombinant beta2-adrenergic receptor expressed in the membrane of Escherichia coli for the multianalyte detection of beta-agonists and antagonists residues in food-producing animals

The on-line incorporation of cloud point extraction (CPE) to flow injection analysis (FIA) was previously based on the use of a cotton-packed column to entrap the analyte-containing surfactant aggregates after salt-induced CPE, and then the preconcentrated analyte was eluted into a separate detection cell for subsequent chemiluminescence (CL) detection (via the peroxyoxalate CL reaction). In the work, the on-line CPE/FIA technique was improved by the following: (1) sample preconcentration and CL detection were both carried out directly inside the collection column, thus avoiding the decrease in detection sensitivity due to sample dispersion and dilution, and (2) CL detection was performed through the reaction between nitrite and hydrogen peroxide, which is compatible with aqueous samples and should allow for chemical excitation to occur more efficiently inside the collection column. In addition to more effective sample preconcentration, the CL detection of the entrapped analytes directly inside the collection column, i.e., a unique heterogeneous microenvironment in which analyte-containing surfactant aggregates were embedded within the densely packed filtering material, may also contribute to the overall increase in CL intensity (e.g., a CL enhancement factor of ca. 1000). Under optimum experimental conditions, the calibration curve was found to be linear for the CL detection of bilirubin (5 to 120 μg L⁻¹), the limit of detection (S/N = 3) was 1.8 μg L⁻¹, and the R.S.D. was ca. 2.6% (n = 30) for 20 μg L⁻¹ bilirubin. Good agreements were obtained for the determination of total bilirubin in certified reference human serum samples between the present approach and an established clinical method.